Perceptive Advisors - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.8%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,450,000
-73.0%
500,000
+46.5%
0.05%
-68.2%
Q4 2022$5,374,514
+0.1%
341,2390.0%0.15%
-3.2%
Q3 2022$5,371,000
+12.7%
341,2390.0%0.16%
+4.7%
Q2 2022$4,764,000
-27.9%
341,239
-11.0%
0.15%
+12.9%
Q1 2022$6,607,000
-70.9%
383,239
-75.5%
0.13%
-24.6%
Q4 2021$22,718,000
+61.6%
1,562,472
+100.0%
0.18%
-14.2%
Q3 2021$14,062,000
-52.9%
781,236
-54.0%
0.20%
+5.2%
Q2 2021$29,852,000
+82.2%
1,700,000
+161.5%
0.19%
-6.3%
Q1 2021$16,380,000
-56.4%
650,000
-48.4%
0.21%
-90.3%
Q1 2017$37,598,000
+9.9%
1,260,8470.0%2.14%
-12.0%
Q4 2016$34,219,000
+210.7%
1,260,847
+193.2%
2.43%
+242.2%
Q3 2016$11,012,000430,0000.71%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 1,258,243$8,618,96513.75%
Foresite Capital Management IV, LLC 2,808,034$19,235,03310.68%
Bain Capital Life Sciences Investors, LLC 3,400,000$23,290,0002.60%
GREAT POINT PARTNERS LLC 1,691,768$11,588,6112.11%
Samsara BioCapital, LLC 696,171$4,768,7711.46%
Altium Capital Management LP 403,000$2,760,5501.44%
BVF INC/IL 7,064,736$48,393,4421.30%
Aisling Capital Management LP 434,455$2,976,0171.23%
GREAT POINT PARTNERS LLC 700,000$4,795,0000.87%
VR Adviser, LLC 1,040,754$7,129,1650.75%
View complete list of ACLARIS THERAPEUTICS INC shareholders